Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells

Laboratory Investigation

Volumn 76, Issue 6, 1997, Pages 779-791

  Ahmed, Asif ^a,b   Dunk, Caroline ^a   Kniss, Douglas ^c   Wilkes, Mark ^b  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GROWTH FACTOR RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PROTEIN TYROSINE KINASE; THYMIDINE; TRITIUM; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TROPHOBLAST;

CALCIUM; CELLS, CULTURED; DNA; DNA PRIMERS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOKINES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; POLYMERASE CHAIN REACTION; PREGNANCY; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030975770     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ahmed A, Li X-F, Dunk C, Whittle MJ, Rushton ID, and Rollason T (1995). Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 12:235-243.
2. Ahmed A, Plevin R, Shaobi M, Fountain SA, Ferriani RA, and Smith SK (1994). Basic FGF activates phospholipase D in endothelial cells in the absence of inositol-lipid hydrolysis. Am J Physiol 266:C206-C212.
3. Appel RG (1990). Mechanism of atrial natriuretic factor-induced inhibition of rat mesangial cell mitogenesis. Am J Physiol 259:E312-E318.
4. Benirschke K and Kaufmann P (1995). Pathology of human placenta. London: Springer-Verlag.
5. Birkenhager R, Schneppe B, Rockl W, Wilting J, Weich HA, and McCarthy JEG (1996). Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor. Biochem J 316:703-707.
6. 2+ and von Willebrand factor in human endothelial cells. Am J Pathol 138:213-221.
7. Charnock-Jones DS, Sharkey A, Boocock CA, Ahmed A, Plevin R, Ferrara N, and Smith SK (1994). Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biol Reprod 51:524-530.
8. 2 in maintaining low vascular tone in fetal placental vessels. Am Physiological Soc H2036-H2043.
9. Clauss M, Weich H, Breier G, Knies U, Rock W, Waltenberger J, and Risau W (1996). The vascular endothelial growth factor receptor Flt-1 mediated biological activities. J Biol Chem 271:17629-17634.
10. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Haymore BL, Neimgruber R, and Feder J (1989). Human vascular permeability factor: Isolation from U937 cells. J Biol Chem 264:20017-20024.
11. Conrad KP, Vill M, McGuire P, Dail WG, and Davis A (1993). Expression of nitric oxide synthase by syncytiotrophoblast in human placental villi. FASEB J 7:1269-1276.
12. Diss EM, Gabbe SG, Moore JW, and Kniss DA (1992). Study of thromboxane and prostacyclin metabolism in an in vitro model of first-trimester human trophoblast. Am J Obstet Gynecol 167:1046-1052.
13. Dvorak HF, Brown LF, Detmar M, and Dvorak AM (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039.
14. Favard C, Moukadiri H, Dorey C, Praloran V, and Plouet J (1991). Purification and biological properties of vasculotropin, a new angiogenic cytokine. Biol Cell 73:1-6.
15. Ferrara N, Houck K, Jakeman L, and Leung DW (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32.
16. Ferriani RA, Ahmed A, Sharkey A, and Smith SK (1994). Colocalisation of acidic and basic fibroblast growth factor (FGF) in human placenta and the cellular effects of bFGF in trophoblast cell line JEG-3. Growth Factors 10:259-268.
17. Firnhaber C and Murrhy ME (1993). Nitric oxide and superoxide in cultured cells: Limited production and influence on DNA synthesis. Am J Physiol 265:R518-R523.
18. Fong GH, Rossant J, Gertsenstein M, and Breitman ML (1995). Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70.
19. Garg UC and Hassid A (1989). Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777.
20. Hibbs JB, Taintor RR, Vavrin Z, and Rachlin EM (1988). Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157:87-94.
21. Houck KA, Leung DW, Rowland AM, Winer J, and Ferrara N (1992). Dual regulation of vascular endothelial growth factor availability by genetic and proteolytic mechanisms. J Biol Chem 267:26031-26037.
22. Jackson MR, Allen L, Morrow RJ, Lye SL, and Ritchie JR (1995). Reduced placental villous tree elaboration in SGA pregnancies: Umbilical artery Doppler waveforms. Am J Obstet Gynecol 1722:518-525.
23. Jakeman LB, Winer J, Bennett GL, Altar CA, and Ferrara N (1992). Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissue. J Clin Invest 89:244-253.
24. Khaliq A, Li X-F, Dunk C, Shams M, Whittle MJ, and Ahmed A (1996a). Placenta growth factor (P1GF) expression and function in human placenta (abstract). Placenta 17:43.
25. Khaliq A, Shams M, Li X-F, Sisi P, Acevedo CA, Weich H, Whittle MJ, and Ahmed A (1996b). Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors 13:243-250.
26. Kilby MD, Afford S, Li X-F, Strain AJ, Ahmed A, and Whittle MJ (1996). Localisation of hepatocyte growth factor and its receptor (c-met) protein and mRNA in human term placenta. Growth Factors 13:133-139.
27. Kim KJ, Li B, Houck K, Winer J, and Ferrara N (1992). The vascular endothelial growth factor proteins: Identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 7:53-64.
28. Lowenstein C and Snyder SH (1992). Nitric oxide, a novel biologic messenger. Cell 70:705-707.
29. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, and Persico MG (1991). Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 88:9267-9271.
30. Molnar M, Suto T, Toth T, and Hertelendy BF (1994). Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 170:1458-1466.
31. Myatt L, Brockman DE, Langdon G, and Pollock JS (1993). Constitutive calcium dependent isoform of NO synthase in the human placental vascular tree. Placenta 14:373-383.
32. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Varticovski L, and Isner JM (1995). Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270:31189-31195.
33. Nanaev A, Chwalisz K, Frank H, Kohnen G, Hegele-Hartung C, and Kaufmann P (1995). Physiological dilation of uteroplacental arteries in the guinea pig depends on nitric oxide synthase activity of extra villous trophoblast. Cell Tissue Res 282:407-421.
34. Plate KH, Breier G, Weich HA, and Risau W (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848.
35. Rutherford RAD, McCarthy A, Sullivan MHF, Elder MG, Polak JM, and Wharton J (1995). Nitric oxide synthase in human placenta and umbilical cord from normal, intrauterine growth-retarded and pre-eclamptic pregnancies. Br J Pharmacol 116:3099-3109.
36. Sanger DR, Perruzzi CA, Feder J, and Dvorak HF (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985.
37. Schlafke S and Enders A (1975). Cellular basis of interaction between trophoblast and uterus at implantation. Biol Reprod 12:41-65.
38. Seymour LW, Shoaibi MA, Martin A, Ahmed A, Elvin P, Kerr D, and Wakelam MJO (1996). Vascular endothelial growth factor stimulates protein kinase C-dependent phospholipase D activity in endothelial cells. Lab Invest 75:427-437.
39. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X-F, Breitman ML, and Schuh AC (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
40. Shams M and Ahmed A (1994). Localization of mRNA for basic fibroblast growth factor in human placenta. Growth Factors 11:105-111.
41. Sharkey AM, Charnock-Jones DS, Boocock CA, Brown KD, and Smith SK (1994). Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil 99:609-615.
42. Shweiki D, Itan A, Soffer D, and Keshet E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxias-initiated angiogenesis. Nature 359:843-845.
43. Waltenburger J, Claesson-Welsh L, Siegbahn A, Shibuya M, and Heldin CH (1994). Different signal transduction properties of KDR and Flt-1: Two receptors for VEGF. J Biol Chem 269:26988-26995.